Thyroid :: FDA acts to ensure thyroid drugs don’t lose potency before expiration date

The U.S. Food and Drug Administration is tightening the potency specifications for levothyroxine sodium, used to treat underactive thyroid glands and other thyroid conditions, to ensure the drug retains its potency over its entire shelf life. This action is being taken in response to concerns that the potency of the drug may deteriorate prior to its expiration date.

Health :: Canada supports the Health Agenda for the Americas

The Honourable Tony Clement, Minister of Health, joined Dr. Mirta Roses, Director of the Pan American Health Organization (PAHO) today to sign the Declaration of the Health Agenda for the Americas, a comprehensive document outlining the vision for health development in the Americas for the period 2008 – 2017.

Drug Safety :: Lilly’s CEO Calls for Reform of Nation’s Drug Safety System

Sidney Taurel, chairman and chief executive officer, Eli Lilly and Company (NYSE: LLY), in a speech at the Cleveland Clinic, called on the health care industry, medical community and U.S. government to actively collaborate on a health information technology system that would provide more rapid and useful insights on the effectiveness of medicines while improving drug safety.

Dr. Anil Singhal Homeopathic Doctor | Dr. Anil Singhal's Blog | Manan - My Memoir by Dr. Anil Singhal | Boger's Legacy | Organon of Medicine | Health Newstrack